Bausch Health Companies Inc. Liability, Defined Benefit Plan, Noncurrent
Bausch Health Companies Inc. (BHC) had Liability, Defined Benefit Plan, Noncurrent of $198.00 million as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent · last filed 2017-11-07
- 2017-09-30: Liability, Defined Benefit Plan, Noncurrent $198.00M.
- 2017-06-30: Liability, Defined Benefit Plan, Noncurrent $201.00M.
- 2017-03-31: Liability, Defined Benefit Plan, Noncurrent $197.00M.
- 2016-12-31: Liability, Defined Benefit Plan, Noncurrent $195.00M.
| Period end | Liability, Defined Benefit Plan, Noncurrent | Liability, Defined Benefit Plan, Noncurrent as first filed |
|---|---|---|
| 2017-09-30 | $198.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $201.00M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $197.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $195.00M 10-Q · filed 2017-11-07 | |
| 2016-09-30 | $190.30M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $191.60M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $194.80M 10-Q · filed 2016-06-07 | |
| 2015-12-31 | $191.00M 10-K · filed 2017-03-01 | $190.40M 10-K · filed 2016-04-29 |
| 2015-09-30 | $221.90M 10-Q · filed 2015-10-26 | |
| 2015-06-30 | $226.40M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $227.70M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $239.80M 10-K · filed 2016-04-29 | |
| 2014-09-30 | $157.70M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $165.50M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $169.00M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $172.00M 10-K · filed 2015-02-25 | $172.02M 10-K · filed 2014-02-28 |
| 2013-09-30 | $230.98M 10-Q · filed 2013-11-01 | |
| 2012-12-31 | $5.33M 10-K · filed 2014-02-28 | $5.30M 10-K · filed 2013-02-28 |
| 2011-12-31 | $6.10M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |